a clinical stage orthobiologics company dedicated to the development
of novel therapeutic soft tissue repair technologies to dramatically
improve the success rate of orthopedic and sports medicine surgeries

Sponsored
Message: VIDEO – ORTHO RTI $ORTH.ca $ORTIF Is Preparing for The Big League, Appointing Patrick O’Donnell to Help Bring its Proprietary Surgery Tech to NASDAQ

VIDEO – ORTHO RTI $ORTH.ca $ORTIF Is Preparing for The Big League, Appointing Patrick O’Donnell to Help Bring its Proprietary Surgery Tech to NASDAQ

posted on Mar 01, 2021 04:17PM

Last week we introduced you to ORTHO Regenerative Technologies, a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.

  • In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.

Now the firm has appointed Patrick O’Donnell to its board of directors.

  • O’Donnell comes with significant company-building experience
  • He will prove crucial in putting this healthcare pioneer on-track for a NASDAQ listing

Claude LeDuc, Ortho’s CEO, breaks down the appointment:

 

Share
New Message
Please login to post a reply